Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Stockholders Approve Solexa-Lynx Merger

NEW YORK, March 1 (GenomeWeb News) - Lynx Therapeutics announced today that its shareholders approved six proposed items - including the company's proposed merger with Solexa - at its annual shareholders meeting held today.

 

The closing of the merger is now subject to acceptance by Solexa shareholders of Lynx's offer to acquire the entire issued share capital of Solexa.

 

Lynx said that it expects the merger to close later this month.

 

The companies announced their plans to merge in August.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.